{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T10:30:41Z","timestamp":1785148241581,"version":"3.55.0"},"reference-count":112,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"University Grants Commission","award":["F.30-312\/2016 (BSR)"],"award-info":[{"award-number":["F.30-312\/2016 (BSR)"]}]},{"DOI":"10.13039\/501100001843","name":"SERB","doi-asserted-by":"crossref","award":["CRG\/2020\/003257"],"award-info":[{"award-number":["CRG\/2020\/003257"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001843","name":"SERB","doi-asserted-by":"crossref","award":["CRG\/2015\/000240"],"award-info":[{"award-number":["CRG\/2015\/000240"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s12035-024-04261-x","type":"journal-article","created":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T15:01:53Z","timestamp":1717254113000},"page":"91-108","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Mechanistic Evaluation of miRNAs and Their Targeted Genes in the Pathogenesis and Therapeutics of Parkinson\u2019s Disease"],"prefix":"10.1007","volume":"62","author":[{"given":"Tania","family":"Arora","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikash","family":"Prashar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randeep","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arti","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harish","family":"Changotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6399-700X","authenticated-orcid":false,"given":"Jyoti","family":"Parkash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,1]]},"reference":[{"key":"4261_CR1","doi-asserted-by":"crossref","unstructured":"Hirsch L, Jette N, Frolkis A, Steeves T, Pringsheim T (2016) The incidence of Parkinson\u2019s disease: a systematic review and meta-analysis. Neuroepidemiology 46:292+","DOI":"10.1159\/000445751"},{"key":"4261_CR2","doi-asserted-by":"publisher","unstructured":"Ou Z, Pan J, Tang S, Duan D, Yu D, Nong H, Wang Z (2021) Global trends in the incidence, prevalence, and years lived with disability of Parkinson\u2019s disease in 204 countries\/territories from 1990 to 2019. Front Public Health 9. https:\/\/doi.org\/10.3389\/fpubh.2021.776847","DOI":"10.3389\/fpubh.2021.776847"},{"issue":"3","key":"4261_CR3","doi-asserted-by":"publisher","first-page":"259","DOI":"10.31887\/DCNS.2004.6.3\/galexander","volume":"6","author":"GE Alexander","year":"2004","unstructured":"Alexander GE (2004) Biology of Parkinson\u2019s disease: pathogenesis and pathophysiology of a multisystem neurodegenerative disorder. Dialog Clin Neurosci 6(3):259\u2013280. https:\/\/doi.org\/10.31887\/DCNS.2004.6.3\/galexander","journal-title":"Dialog Clin Neurosci"},{"key":"4261_CR4","doi-asserted-by":"publisher","unstructured":"Groiss SJ, Wojtecki L, S\u00fcdmeyer M, Schnitzler A (2009) Review: deep brain stimulation in Parkinson\u2019s disease. 2(6):379\u2013391. https:\/\/doi.org\/10.1177\/1756285609339382","DOI":"10.1177\/1756285609339382"},{"key":"4261_CR5","doi-asserted-by":"publisher","unstructured":"Lindvall O (2015) Treatment of Parkinson\u2019s disease using cell transplantation. 370(1680):20140370. https:\/\/doi.org\/10.1098\/rstb.2014.0370","DOI":"10.1098\/rstb.2014.0370"},{"issue":"4","key":"4261_CR6","doi-asserted-by":"publisher","first-page":"a009431","DOI":"10.1101\/cshperspect.a009431","volume":"2","author":"PG Coune","year":"2012","unstructured":"Coune PG, Schneider BL, Aebischer P (2012) Parkinson\u2019s disease: gene therapies. Cold Spring Harbor Perspect Med 2(4):a009431. https:\/\/doi.org\/10.1101\/cshperspect.a009431","journal-title":"Cold Spring Harbor Perspect Med"},{"issue":"5","key":"4261_CR7","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/0092-8674(93)90529-Y","volume":"75","author":"RC Lee","year":"1993","unstructured":"Lee RC, Feinbaum RL, Ambros V (1993) The C. Elegans heterochronic gene\u2009<\u2009em\u2009>\u2009lin-4\u2009encodes small RNAs with antisense complementarity to <\u2009em\u2009>\u2009lin-14. Cell 75(5):843\u2013854. https:\/\/doi.org\/10.1016\/0092-8674(93)90529-Y","journal-title":"Cell"},{"key":"4261_CR8","doi-asserted-by":"publisher","unstructured":"Kye MJ, Gon\u00e7alves IC (2014) The role of miRNA in motor neuron disease. 8(15). https:\/\/doi.org\/10.3389\/fncel.2014.00015","DOI":"10.3389\/fncel.2014.00015"},{"key":"4261_CR9","doi-asserted-by":"publisher","unstructured":"Xu L, Pu J (2016) Alpha-Synuclein in Parkinson\u2019s Disease: From Pathogenetic Dysfunction to Potential Clinical Application. Parkinson\u2019s Disease 2016:1720621. https:\/\/doi.org\/10.1155\/2016\/1720621","DOI":"10.1155\/2016\/1720621"},{"issue":"3","key":"4261_CR10","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1093\/hmg\/dds470","volume":"22","author":"HJ Cho","year":"2012","unstructured":"Cho HJ, Liu G, Jin SM, Parisiadou L, Xie C, Yu J, Sun L, Ma B, Ding J, Vancraenenbroeck R, Lobbestael E, Baekelandt V, Taymans J-M, He P, Troncoso JC, Shen Y, Cai H (2012) MicroRNA-205 regulates the expression of Parkinson\u2019s disease-related leucine-rich repeat kinase 2 protein. Hum Mol Genet 22(3):608\u2013620. https:\/\/doi.org\/10.1093\/hmg\/dds470. Human Molecular Genetics","journal-title":"Hum Mol Genet"},{"issue":"8","key":"4261_CR11","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/nrclinonc.2011.76","volume":"8","author":"MA Cortez","year":"2011","unstructured":"Cortez MA, Bueso-Ramos C, Ferdin J, Lopez-Berestein G, Sood AK, Calin GA (2011) MicroRNAs in body fluids\u2014the mix of hormones and biomarkers. Nat Reviews Clin Oncol 8(8):467\u2013477. https:\/\/doi.org\/10.1038\/nrclinonc.2011.76","journal-title":"Nat Reviews Clin Oncol"},{"issue":"10","key":"4261_CR12","doi-asserted-by":"publisher","first-page":"7736","DOI":"10.1007\/s12035-016-0253-0","volume":"54","author":"TM Marques","year":"2017","unstructured":"Marques TM, Kuiperij HB, Bruinsma IB, van Rumund A, Aerts MB, Esselink RAJ, Bloem BR, Verbeek MM (2017) MicroRNAs in cerebrospinal fluid as potential biomarkers for Parkinson\u2019s disease and multiple system atrophy. Mol Neurobiol 54(10):7736\u20137745. https:\/\/doi.org\/10.1007\/s12035-016-0253-0","journal-title":"Mol Neurobiol"},{"issue":"4","key":"4261_CR13","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s00268-008-9836-x","volume":"33","author":"M Li","year":"2009","unstructured":"Li M, Marin-Muller C, Bharadwaj U, Chow K-H, Yao Q, Chen C (2009) MicroRNAs: control and loss of control in human physiology and disease. World J Surg 33(4):667\u2013684. https:\/\/doi.org\/10.1007\/s00268-008-9836-x","journal-title":"World J Surg"},{"issue":"1\u20132","key":"4261_CR14","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.gene.2011.03.005","volume":"480","author":"VA Gennarino","year":"2011","unstructured":"Gennarino VA, Sardiello M, Mutarelli M, Dharmalingam G, Maselli V, Lago G, Banfi S (2011) HOCTAR database: a unique resource for microRNA target prediction. Gene 480(1\u20132):51\u201358. https:\/\/doi.org\/10.1016\/j.gene.2011.03.005","journal-title":"Gene"},{"key":"4261_CR15","doi-asserted-by":"publisher","unstructured":"O\u2019Brien J, Hayder H, Zayed Y, Peng C (2018) Overview of microRNA biogenesis, mechanisms of actions, and circulation. 9(402). https:\/\/doi.org\/10.3389\/fendo.2018.00402","DOI":"10.3389\/fendo.2018.00402"},{"issue":"7014","key":"4261_CR16","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nature03049","volume":"432","author":"AM Denli","year":"2004","unstructured":"Denli AM, Tops BBJ, Plasterk RHA, Ketting RF, Hannon GJ (2004) Processing of primary microRNAs by the Microprocessor complex. Nature 432(7014):231\u2013235. https:\/\/doi.org\/10.1038\/nature03049","journal-title":"Nature"},{"issue":"2","key":"4261_CR17","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.gpb.2017.09.004","volume":"16","author":"K Wu","year":"2018","unstructured":"Wu K, He J, Pu W, Peng Y (2018) The role of Exportin-5 in microRNA biogenesis and cancer. Genom Proteom Bioinform 16(2):120\u2013126. https:\/\/doi.org\/10.1016\/j.gpb.2017.09.004","journal-title":"Genom Proteom Bioinform"},{"issue":"11","key":"4261_CR18","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1016\/j.biochi.2011.06.017","volume":"93","author":"JO Westholm","year":"2011","unstructured":"Westholm JO, Lai EC (2011) Mirtrons: microRNA biogenesis via splicing. Biochimie 93(11):1897\u20131904. https:\/\/doi.org\/10.1016\/j.biochi.2011.06.017","journal-title":"Biochimie"},{"issue":"10","key":"4261_CR19","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1042\/bcj20160759","volume":"474","author":"MS Song","year":"2017","unstructured":"Song MS, Rossi JJ (2017) Molecular mechanisms of Dicer: endonuclease and enzymatic activity. Biochem J 474(10):1603\u20131618. https:\/\/doi.org\/10.1042\/bcj20160759","journal-title":"Biochem J"},{"issue":"27","key":"4261_CR20","doi-asserted-by":"publisher","first-page":"17897","DOI":"10.1074\/jbc.R900012200","volume":"284","author":"AJ Pratt","year":"2009","unstructured":"Pratt AJ, MacRae IJ (2009) The RNA-induced silencing complex: a versatile gene-silencing machine. J Biol Chem 284(27):17897\u201317901. https:\/\/doi.org\/10.1074\/jbc.R900012200","journal-title":"J Biol Chem"},{"key":"4261_CR21","doi-asserted-by":"publisher","unstructured":"Mayr C (2017) Regulation by 3\u2032-untranslated regions. 51(1):171\u2013194. https:\/\/doi.org\/10.1146\/annurev-genet-120116-024704","DOI":"10.1146\/annurev-genet-120116-024704"},{"issue":"1","key":"4261_CR22","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12986-018-0305-8","volume":"15","author":"Z Li","year":"2018","unstructured":"Li Z, Xu R, Li N (2018) MicroRNAs from plants to animals, do they define a new messenger for communication? Nutr Metabolism 15(1):68. https:\/\/doi.org\/10.1186\/s12986-018-0305-8","journal-title":"Nutr Metabolism"},{"issue":"11","key":"4261_CR23","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.tig.2015.09.002","volume":"31","author":"T Desvignes","year":"2015","unstructured":"Desvignes T, Batzel P, Berezikov E, Eilbeck K, Eppig JT, McAndrews MS, Singer A, Postlethwait JH (2015) miRNA nomenclature: a view incorporating genetic origins, biosynthetic pathways, and sequence variants. Trends Genet 31(11):613\u2013626. https:\/\/doi.org\/10.1016\/j.tig.2015.09.002","journal-title":"Trends Genet"},{"key":"4261_CR24","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.anorl.2011.03.002","volume":"128","author":"L Sakka","year":"2011","unstructured":"Sakka L, Coll G, Chazal J (2011) Anatomy and physiology of cerebrospinal fluid. European annals of otorhinolaryngology. head neck Dis 128:309\u2013316. https:\/\/doi.org\/10.1016\/j.anorl.2011.03.002","journal-title":"head neck Dis"},{"key":"4261_CR25","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.1016\/j.parkreldis.2020.06.065","volume":"79","author":"X Tan","year":"2020","unstructured":"Tan X, Tan J, Ming F, Lv L, Zhang H, Tang B, Yan W, Peng X, Bai R, Xiao Q, Wang C (2020) Up-regulation of mir-409-3p in cerebrospinal fluid of Parkinson\u2019s disease reduce the apoptosis of dopamine neurons. Parkinsonism Relat Disord 79:e10\u2013e11. https:\/\/doi.org\/10.1016\/j.parkreldis.2020.06.065","journal-title":"Parkinsonism Relat Disord"},{"key":"4261_CR26","doi-asserted-by":"publisher","unstructured":"Qin L-X, Tan J-Q, Zhang H-N, Tang J-G, Jiang B, Shen X-M, Guo J-F, Tan L-M, Tang B, Wang C-Y (2021) Preliminary study of hsa-mir-626 change in the cerebrospinal fluid in Parkinson\u2019s disease.  69(1):115-118. https:\/\/doi.org\/10.4103\/0028-3886.310102","DOI":"10.4103\/0028-3886.310102"},{"issue":"12","key":"4261_CR27","doi-asserted-by":"publisher","first-page":"a009621","DOI":"10.1101\/cshperspect.a009621","volume":"2","author":"JL Lanciego","year":"2012","unstructured":"Lanciego JL, Luquin N, Obeso JA (2012) Functional neuroanatomy of the basal ganglia. Cold Spring Harb Perspect Med 2(12):a009621. https:\/\/doi.org\/10.1101\/cshperspect.a009621","journal-title":"Cold Spring Harb Perspect Med"},{"key":"4261_CR28","doi-asserted-by":"publisher","unstructured":"Del Tredici K, R\u00fcb U, de Vos RAI, Bohl JRE, Braak H (2002) Where does Parkinson disease pathology begin in the brain? J Neuropathol Exp Neurol 61 (5):413\u2013426. https:\/\/doi.org\/10.1093\/jnen\/61.5.413","DOI":"10.1093\/jnen\/61.5.413"},{"issue":"1","key":"4261_CR29","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3892\/ijmm.2018.3982","volume":"43","author":"JX Gao","year":"2019","unstructured":"Gao JX, Li Y, Wang SN, Chen XC, Lin LL, Zhang H (2019) Overexpression of microRNA-183 promotes apoptosis of substantia nigra neurons via the inhibition of OSMR in a mouse model of Parkinson\u2019s disease. Int J Mol Med 43(1):209\u2013220. https:\/\/doi.org\/10.3892\/ijmm.2018.3982","journal-title":"Int J Mol Med"},{"key":"4261_CR30","doi-asserted-by":"publisher","unstructured":"Thome AD, Harms AS, Volpicelli-Daley LA, Standaert DG (2016) MicroRNA-155 regulates alpha-synuclein-induced inflammatory responses in models of Parkinson disease. J Neurosci 36(8):2383\u20132390. https:\/\/doi.org\/10.1523\/JNEUROSCI.3900-15","DOI":"10.1523\/JNEUROSCI.3900-15"},{"key":"4261_CR31","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.brainresbull.2020.10.019","volume":"166","author":"X Ma","year":"2021","unstructured":"Ma X, Zhang H, Yin H, Geng S, Liu Y, Liu C, Zhao J, Liu Y, Wang X, Wang Y (2021) Up-regulated microRNA-218-5p ameliorates the damage of dopaminergic neurons in rats with Parkinson\u2019s disease via suppression of LASP1. Brain Res Bull 166:92\u2013101. https:\/\/doi.org\/10.1016\/j.brainresbull.2020.10.019","journal-title":"Brain Res Bull"},{"key":"4261_CR32","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3389\/fnmol.2018.00381","volume":"11","author":"S Sun","year":"2018","unstructured":"Sun S, Han X, Li X, Song Q, Lu M, Jia M, Ding J, Hu G (2018) MicroRNA-212-5p prevents dopaminergic neuron death by inhibiting SIRT2 in MPTP-induced mouse model of Parkinson\u2019s disease. Front Mol Neurosci 11:381. https:\/\/doi.org\/10.3389\/fnmol.2018.00381","journal-title":"Front Mol Neurosci"},{"key":"4261_CR33","doi-asserted-by":"publisher","unstructured":"Xicoy H, Wieringa B, Martens G (2017) The SH-SY5Y cell line in Parkinson\u2019s disease research: a systematic review. Mol Neurodegeneration 12. https:\/\/doi.org\/10.1186\/s13024-017-0149-0","DOI":"10.1186\/s13024-017-0149-0"},{"issue":"2","key":"4261_CR34","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3892\/ijmm.2019.4426","volume":"45","author":"H Tao","year":"2020","unstructured":"Tao H, Liu Y, Hou Y (2020) miRNA\u2013384\u20135p regulates the progression of Parkinson\u2019s disease by targeting SIRT1 in mice and SH\u2013SY5Y cell. Int J Mol Med 45(2):441\u2013450. https:\/\/doi.org\/10.3892\/ijmm.2019.4426","journal-title":"Int J Mol Med"},{"key":"4261_CR35","doi-asserted-by":"publisher","unstructured":"Zhao J, Yang M, Li Q, Pei X, Zhu X (2020) Mir-132-5p regulates apoptosis and autophagy in MPTP model of Parkinson\u2019s disease by targeting ULK1. 31(13):959\u2013965. https:\/\/doi.org\/10.1097\/wnr.0000000000001494","DOI":"10.1097\/wnr.0000000000001494"},{"issue":"8","key":"4261_CR36","first-page":"4179","volume":"11","author":"J Zhu","year":"2018","unstructured":"Zhu J, Wang S, Qi W, Xu X, Liang Y (2018) Overexpression of miR-153 promotes oxidative stress in MPP(+)-induced PD model by negatively regulating the Nrf2\/HO-1 signaling pathway. Int J Clin Exp Pathol 11(8):4179\u20134187","journal-title":"Int J Clin Exp Pathol"},{"key":"4261_CR37","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.neulet.2019.02.038","volume":"701","author":"Z Wang","year":"2019","unstructured":"Wang Z, Sun L, Jia K, Wang H, Wang X (2019) Mir-9-5p modulates the progression of Parkinson\u2019s disease by targeting SIRT1. Neurosci Lett 701:226\u2013233. https:\/\/doi.org\/10.1016\/j.neulet.2019.02.038","journal-title":"Neurosci Lett"},{"key":"4261_CR38","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ejphar.2018.07.023","volume":"835","author":"J Zhu","year":"2018","unstructured":"Zhu J, Wang S, Liang Y, Xu X (2018) Inhibition of microRNA-505 suppressed MPP+ -induced cytotoxicity of SHSY5Y cells in an in vitro Parkinson\u2019s disease model. Eur J Pharmacol 835:11\u201318. https:\/\/doi.org\/10.1016\/j.ejphar.2018.07.023","journal-title":"Eur J Pharmacol"},{"key":"4261_CR39","doi-asserted-by":"publisher","unstructured":"Zhu J, Xu X, Liang Y, Zhu R (2021) Downregulation of microRNA-15b-5p targeting the Akt3-mediated GSK-3\u03b2\/\u03b2-catenin\u00a0signaling pathway inhibits cell apoptosis in Parkinson\u2019s disease. BioMed Res Int 2021:8814862. https:\/\/doi.org\/10.1155\/2021\/8814862","DOI":"10.1155\/2021\/8814862"},{"issue":"1","key":"4261_CR40","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12974-018-1053-4","volume":"15","author":"L Yao","year":"2018","unstructured":"Yao L, Ye Y, Mao H, Lu F, He X, Lu G, Zhang S (2018) MicroRNA-124 regulates the expression of MEKK3 in the inflammatory pathogenesis of Parkinson\u2019s disease. J Neuroinflammation 15(1):13. https:\/\/doi.org\/10.1186\/s12974-018-1053-4","journal-title":"J Neuroinflammation"},{"key":"4261_CR41","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.tiv.2017.10.003","volume":"46","author":"P Tarale","year":"2018","unstructured":"Tarale P, Daiwile AP, Sivanesan S, St\u00f6ger R, Bafana A, Naoghare PK, Parmar D, Chakrabarti T, Krishnamurthi K (2018) Manganese exposure: linking down-regulation of miRNA-7 and miRNA-433 with \u03b1-synuclein overexpression and risk of idiopathic Parkinson\u2019s disease. Toxicol in Vitro 46:94\u2013101. https:\/\/doi.org\/10.1016\/j.tiv.2017.10.003","journal-title":"Toxicol in Vitro"},{"issue":"3","key":"4261_CR42","doi-asserted-by":"publisher","first-page":"e548","DOI":"10.1002\/mgg3.548","volume":"7","author":"M Talepoor Ardakani","year":"2019","unstructured":"Talepoor Ardakani M, Rostamian Delavar M, Baghi M, Nasr-Esfahani MH, Kiani-Esfahani A, Ghaedi K (2019) Upregulation of miR-200a and miR-204 in MPP(+) -treated differentiated PC12 cells as a model of Parkinson\u2019s disease. Mol Genet Genomic Med 7(3):e548. https:\/\/doi.org\/10.1002\/mgg3.548","journal-title":"Mol Genet Genomic Med"},{"key":"4261_CR43","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.gene.2018.04.010","volume":"662","author":"M Rostamian Delavar","year":"2018","unstructured":"Rostamian Delavar M, Baghi M, Safaeinejad Z, Kiani-Esfahani A, Ghaedi K, Nasr-Esfahani MH (2018) Differential expression of miR-34a, miR-141, and miR-9 in MPP+-treated differentiated PC12 cells as a model of Parkinson\u2019s disease. Gene 662:54\u201365. https:\/\/doi.org\/10.1016\/j.gene.2018.04.010","journal-title":"Gene"},{"issue":"8","key":"4261_CR44","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41419-019-1809-5","volume":"10","author":"YB Hu","year":"2019","unstructured":"Hu YB, Zhang YF, Wang H, Ren RJ, Cui HL, Huang WY, Cheng Q, Chen HZ, Wang G (2019) miR-425 deficiency promotes necroptosis and dopaminergic neurodegeneration in Parkinson\u2019s disease. Cell Death Dis 10(8):589. https:\/\/doi.org\/10.1038\/s41419-019-1809-5","journal-title":"Cell Death Dis"},{"issue":"4","key":"4261_CR45","doi-asserted-by":"publisher","first-page":"958","DOI":"10.3390\/cells9040958","volume":"9","author":"B Wiatrak","year":"2020","unstructured":"Wiatrak B, Kubis-Kubiak A, Piwowar A, Barg E (2020) PC12 cell line: cell types, coating of culture vessels, differentiation and other culture conditions. Cells 9(4):958. https:\/\/doi.org\/10.3390\/cells9040958","journal-title":"Cells"},{"key":"4261_CR46","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/B978-0-12-374028-1.00029-4","volume-title":"Parkinson\u2019s Disease","author":"C Malagelada","year":"2008","unstructured":"Malagelada C, Greene LA (2008) Chap. 29 - PC12 cells as a model for parkinson\u2019s disease research. In: Nass R, Przedborski S (eds) Parkinson\u2019s Disease. Academic, San Diego, pp 375\u2013387. doi:https:\/\/doi.org\/10.1016\/B978-0-12-374028-1.00029-4"},{"key":"4261_CR47","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.neulet.2018.09.034","volume":"687","author":"L Jin","year":"2018","unstructured":"Jin L, Wan W, Wang L, Wang C, Xiao J, Zhang F, Zhao J, Wang J, Zhan C, Zhong C (2018) Elevated microRNA-520d-5p in the serum of patients with Parkinson\u2019s disease, possibly through regulation of cereloplasmin expression. Neurosci Lett 687:88\u201393. https:\/\/doi.org\/10.1016\/j.neulet.2018.09.034","journal-title":"Neurosci Lett"},{"key":"4261_CR48","doi-asserted-by":"publisher","unstructured":"Oliveira SR, Dion\u00edsio PA, Correia Guedes L, Gon\u00e7alves N, Coelho M, Rosa MM, Amaral JD, Ferreira JJ, Rodrigues CMP (2020) Circulating inflammatory miRNAs associated with Parkinson\u2019s disease pathophysiology. Biomolecules 10(6). https:\/\/doi.org\/10.3390\/biom10060945","DOI":"10.3390\/biom10060945"},{"issue":"13","key":"4261_CR49","doi-asserted-by":"publisher","first-page":"13518","DOI":"10.18632\/aging.103458","volume":"12","author":"L Han","year":"2020","unstructured":"Han L, Tang Y, Bai X, Liang X, Fan Y, Shen Y, Huang F, Wang J (2020) Association of the serum microRNA-29 family with cognitive impairment in Parkinson\u2019s disease. Aging 12(13):13518\u201313528. https:\/\/doi.org\/10.18632\/aging.103458","journal-title":"Aging"},{"key":"4261_CR50","doi-asserted-by":"publisher","unstructured":"Chen L, Yang J, L\u00fc J, Cao S, Zhao Q, Yu Z (2018) Identification of aberrant circulating miRNAs in Parkinson\u2019s disease plasma samples. 8(4):e00941. https:\/\/doi.org\/10.1002\/brb3.941","DOI":"10.1002\/brb3.941"},{"key":"4261_CR51","doi-asserted-by":"publisher","unstructured":"Yang Z, Li T, Cui Y, Li S, Cheng C, Shen B, Le W (2019) Elevated plasma microRNA-105-5p level in patients with idiopathic Parkinson\u2019s disease: a potential disease biomarker. 13(218). https:\/\/doi.org\/10.3389\/fnins.2019.00218","DOI":"10.3389\/fnins.2019.00218"},{"issue":"2","key":"4261_CR52","doi-asserted-by":"publisher","first-page":"533","DOI":"10.3892\/ijmm.2020.4806","volume":"47","author":"I Grossi","year":"2021","unstructured":"Grossi I, Radeghieri A, Paolini L, Porrini V, Pilotto A, Padovani A, Marengoni A, Barbon A, Bellucci A, Pizzi M, Salvi A, De Petro G (2021) MicroRNA\u201334a\u20135p expression in the plasma and in its extracellular vesicle fractions in subjects with Parkinson\u2019s disease: an exploratory study. Int J Mol Med 47(2):533\u2013546. https:\/\/doi.org\/10.3892\/ijmm.2020.4806","journal-title":"Int J Mol Med"},{"issue":"5","key":"4261_CR53","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s10072-017-2841-9","volume":"38","author":"N Li","year":"2017","unstructured":"Li N, Pan X, Zhang J, Ma A, Yang S, Ma J, Xie A (2017) Plasma levels of miR-137 and miR-124 are associated with Parkinson\u2019s disease but not with Parkinson\u2019s disease with depression. Neurol Sci 38(5):761\u2013767. https:\/\/doi.org\/10.1007\/s10072-017-2841-9","journal-title":"Neurol Sci"},{"key":"4261_CR54","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3389\/fncel.2017.00170","volume":"11","author":"X Zhang","year":"2017","unstructured":"Zhang X, Yang R, Hu BL, Lu P, Zhou LL, He ZY, Wu HM, Zhu JH (2017) Reduced circulating levels of miR-433 and miR-133b are potential biomarkers for Parkinson\u2019s disease. Front Cell Neurosci 11:170. https:\/\/doi.org\/10.3389\/fncel.2017.00170","journal-title":"Front Cell Neurosci"},{"issue":"4","key":"4261_CR55","first-page":"979","volume":"14","author":"J Pourahmad","year":"2015","unstructured":"Pourahmad J, Salimi A (2015) Isolated human peripheral blood mononuclear cell (PBMC), a cost effective tool for predicting immunosuppressive effects of drugs and xenobiotics. Iran J Pharm Research: IJPR 14(4):979","journal-title":"Iran J Pharm Research: IJPR"},{"key":"4261_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ensci.2018.09.002","volume":"13","author":"E Caggiu","year":"2018","unstructured":"Caggiu E, Paulus K, Mameli G, Arru G, Sechi GP, Sechi LA (2018) Differential expression of miRNA 155 and miRNA 146a in Parkinson\u2019s disease patients. eNeurologicalSci 13:1\u20134. https:\/\/doi.org\/10.1016\/j.ensci.2018.09.002","journal-title":"eNeurologicalSci"},{"issue":"1","key":"4261_CR57","doi-asserted-by":"publisher","first-page":"13759","DOI":"10.1038\/s41598-019-50256-3","volume":"9","author":"M Behbahanipour","year":"2019","unstructured":"Behbahanipour M, Peymani M, Salari M, Hashemi MS, Nasr-Esfahani MH, Ghaedi K (2019) Expression profiling of blood microRNAs 885, 361, and 17 in the patients with the Parkinson\u2019s disease: integrating interaction data to uncover the possible triggering age-related mechanisms. Sci Rep 9(1):13759. https:\/\/doi.org\/10.1038\/s41598-019-50256-3","journal-title":"Sci Rep"},{"issue":"4","key":"4261_CR58","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1111\/jcmm.14979","volume":"24","author":"M Baghi","year":"2020","unstructured":"Baghi M, Rostamian Delavar M, Yadegari E, Peymani M, Pozo D, Hossein Nasr-Esfahani M, Ghaedi K (2020) Modified level of miR-376a is associated with Parkinson\u2019s disease. J Cell Mol Med 24(4):2622\u20132634. https:\/\/doi.org\/10.1111\/jcmm.14979","journal-title":"J Cell Mol Med"},{"issue":"11","key":"4261_CR59","doi-asserted-by":"publisher","first-page":"e0240855","DOI":"10.1371\/journal.pone.0240855","volume":"15","author":"S Fazeli","year":"2020","unstructured":"Fazeli S, Motovali-Bashi M, Peymani M, Hashemi MS, Etemadifar M, Nasr-Esfahani MH, Ghaedi K (2020) A compound downregulation of SRRM2 and miR-27a-3p with upregulation of miR-27b-3p in PBMCs of Parkinson\u2019s patients is associated with the early stage onset of disease. PLoS ONE 15(11):e0240855. https:\/\/doi.org\/10.1371\/journal.pone.0240855","journal-title":"PLoS ONE"},{"issue":"6","key":"4261_CR60","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.3892\/mmr.2014.2080","volume":"9","author":"DW Li","year":"2014","unstructured":"Li DW, Liu ZQ, Chen W, Yao M, Li GR (2014) Association of glycogen synthase kinase-3\u03b2 with Parkinson\u2019s disease (review). Mol Med Rep 9(6):2043\u20132050. https:\/\/doi.org\/10.3892\/mmr.2014.2080","journal-title":"Mol Med Rep"},{"key":"4261_CR61","doi-asserted-by":"publisher","unstructured":"Chen Y, Zheng J, Su L, Chen F, Zhu R, Chen X, Ye Q (2020) Increased salivary microRNAs that regulate DJ-1 gene expression as potential markers for Parkinson\u2019s disease. 12(210). https:\/\/doi.org\/10.3389\/fnagi.2020.00210","DOI":"10.3389\/fnagi.2020.00210"},{"issue":"1","key":"4261_CR62","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13024-019-0329-1","volume":"14","author":"RM Meade","year":"2019","unstructured":"Meade RM, Fairlie DP, Mason JM (2019) Alpha-synuclein structure and Parkinson\u2019s disease \u2013 lessons and emerging principles. Mol Neurodegeneration 14(1):29. https:\/\/doi.org\/10.1186\/s13024-019-0329-1","journal-title":"Mol Neurodegeneration"},{"issue":"3","key":"4261_CR63","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1016\/j.neurobiolaging.2014.10.042","volume":"36","author":"W Xu","year":"2015","unstructured":"Xu W, Tan L, Yu J-T (2015) Link between the SNCA gene and parkinsonism. Neurobiol Aging 36(3):1505\u20131518. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.10.042","journal-title":"Neurobiol Aging"},{"issue":"3","key":"4261_CR64","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/77060","volume":"25","author":"H Shimura","year":"2000","unstructured":"Shimura H, Hattori N, Kubo S, Mizuno Y, Asakawa S, Minoshima S, Shimizu N, Iwai K, Chiba T, Tanaka K, Suzuki T (2000) Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat Genet 25(3):302\u2013305. https:\/\/doi.org\/10.1038\/77060","journal-title":"Nat Genet"},{"issue":"8","key":"4261_CR65","doi-asserted-by":"publisher","first-page":"4281","DOI":"10.1073\/pnas.1909814117","volume":"117","author":"SJ Ham","year":"2020","unstructured":"Ham SJ, Lee D, Yoo H, Jun K, Shin H, Chung J (2020) Decision between mitophagy and apoptosis by Parkin via VDAC1 ubiquitination. Proc Natl Acad Sci USA 117(8):4281\u20134291. https:\/\/doi.org\/10.1073\/pnas.1909814117","journal-title":"Proc Natl Acad Sci USA"},{"key":"4261_CR66","doi-asserted-by":"publisher","unstructured":"Nies YH, Mohamad Najib NH, Lim WL, Kamaruzzaman MA, Yahaya MF, Teoh SL (2021) MicroRNA dysregulation in Parkinson\u2019s disease: a narrative review. Front NeuroSci 15. https:\/\/doi.org\/10.3389\/fnins.2021.660379","DOI":"10.3389\/fnins.2021.660379"},{"key":"4261_CR67","doi-asserted-by":"publisher","unstructured":"Oliveira SR, Dion\u00edsio PA, Correia Guedes L, Gon\u00e7alves N, Coelho M, Rosa MM, Amaral JD, Ferreira JJ, Rodrigues CMP (2020) Circulating inflammatory miRNAs associated with Parkinson\u2019s disease pathophysiology. 10(6). https:\/\/doi.org\/10.3390\/biom10060945","DOI":"10.3390\/biom10060945"},{"issue":"46","key":"4261_CR68","doi-asserted-by":"publisher","first-page":"31315","DOI":"10.1074\/jbc.M805371200","volume":"283","author":"WJ Lukiw","year":"2008","unstructured":"Lukiw WJ, Zhao Y, Cui JG (2008) An NF-kappaB-sensitive micro RNA-146a-mediated inflammatory circuit in Alzheimer disease and in stressed human brain cells. J Biol Chem 283(46):31315\u201331322. https:\/\/doi.org\/10.1074\/jbc.M805371200","journal-title":"J Biol Chem"},{"issue":"6131","key":"4261_CR69","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1126\/science.1231031","volume":"340","author":"Y Chen","year":"2013","unstructured":"Chen Y, Dorn GW 2nd (2013) PINK1-phosphorylated mitofusin 2 is a parkin receptor for culling damaged mitochondria. Sci (New York NY) 340(6131):471\u2013475. https:\/\/doi.org\/10.1126\/science.1231031","journal-title":"Sci (New York NY)"},{"issue":"4","key":"4261_CR70","doi-asserted-by":"publisher","first-page":"e00941","DOI":"10.1002\/brb3.941","volume":"8","author":"L Chen","year":"2018","unstructured":"Chen L, Yang J, L\u00fc J, Cao S, Zhao Q, Yu Z (2018) Identification of aberrant circulating miRNAs in Parkinson\u2019s disease plasma samples. Brain Behav 8(4):e00941\u2013e00941. https:\/\/doi.org\/10.1002\/brb3.941","journal-title":"Brain Behav"},{"issue":"5","key":"4261_CR71","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1110\/ps.073411608","volume":"17","author":"G Malgieri","year":"2008","unstructured":"Malgieri G, Eliezer D (2008) Structural effects of Parkinson\u2019s disease linked DJ-1 mutations. Protein Science: Publication Protein Soc 17(5):855\u2013868. https:\/\/doi.org\/10.1110\/ps.073411608","journal-title":"Protein Science: Publication Protein Soc"},{"issue":"15","key":"4261_CR72","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1093\/hmg\/ddr210","volume":"20","author":"E Mi\u00f1ones-Moyano","year":"2011","unstructured":"Mi\u00f1ones-Moyano E, Porta S, Escaram\u00eds G, Rabionet R, Iraola S, Kagerbauer B, Espinosa-Parrilla Y, Ferrer I, Estivill X, Mart\u00ed E (2011) MicroRNA profiling of Parkinson\u2019s disease brains identifies early downregulation of miR-34b\/c which modulate mitochondrial function. Hum Mol Genet 20(15):3067\u20133078. https:\/\/doi.org\/10.1093\/hmg\/ddr210","journal-title":"Hum Mol Genet"},{"key":"4261_CR73","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.parkreldis.2016.09.028","volume":"33","author":"R Tatura","year":"2016","unstructured":"Tatura R, Kraus T, Giese A, Arzberger T, Buchholz M, H\u00f6glinger G, M\u00fcller U (2016) Parkinson\u2019s disease: SNCA-, PARK2-, and LRRK2-targeting microRNAs elevated in cingulate gyrus. Parkinsonism Relat Disord 33:115\u2013121","journal-title":"Parkinsonism Relat Disord"},{"key":"4261_CR74","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.freeradbiomed.2015.09.010","volume":"89","author":"S Kabaria","year":"2015","unstructured":"Kabaria S, Choi DC, Chaudhuri AD, Jain MR, Li H, Junn E (2015) MicroRNA-7 activates Nrf2 pathway by targeting Keap1 expression. Free Radic Biol Med 89:548\u2013556","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"4261_CR75","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/ana.20791","volume":"59","author":"BI Giasson","year":"2006","unstructured":"Giasson BI, Covy JP, Bonini NM, Hurtig HI, Farrer MJ, Trojanowski JQ, Van Deerlin VM (2006) Biochemical and pathological characterization of Lrrk2. Ann Neurol 59(2):315\u2013322","journal-title":"Ann Neurol"},{"issue":"5","key":"4261_CR76","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.tins.2006.03.006","volume":"29","author":"IF Mata","year":"2006","unstructured":"Mata IF, Wedemeyer WJ, Farrer MJ, Taylor JP, Gallo KA (2006) LRRK2 in Parkinson\u2019s disease: protein domains and functional insights. Trends Neurosci 29(5):286\u2013293. https:\/\/doi.org\/10.1016\/j.tins.2006.03.006","journal-title":"Trends Neurosci"},{"issue":"2","key":"4261_CR77","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41582-019-0301-2","volume":"16","author":"E Tolosa","year":"2020","unstructured":"Tolosa E, Vila M, Klein C, Rascol O (2020) LRRK2 in Parkinson disease: challenges of clinical trials. Nat Reviews Neurol 16(2):97\u2013107. https:\/\/doi.org\/10.1038\/s41582-019-0301-2","journal-title":"Nat Reviews Neurol"},{"issue":"12","key":"4261_CR78","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.1093\/brain\/awz324","volume":"142","author":"K Chandrasekaran","year":"2019","unstructured":"Chandrasekaran K, Salimian M, Konduru SR, Choi J, Kumar P, Long A, Klimova N, Ho C-Y, Kristian T, Russell JW (2019) Overexpression of Sirtuin 1 protein in neurons prevents and reverses experimental diabetic neuropathy. Brain 142(12):3737\u20133752. https:\/\/doi.org\/10.1093\/brain\/awz324","journal-title":"Brain"},{"issue":"3\u20134","key":"4261_CR79","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1177\/1947601913484497","volume":"4","author":"R Raynes","year":"2013","unstructured":"Raynes R, Brunquell J, Westerheide SD (2013) Stress inducibility of SIRT1 and its role in Cytoprotection and Cancer. Genes Cancer 4(3\u20134):172\u2013182. https:\/\/doi.org\/10.1177\/1947601913484497","journal-title":"Genes Cancer"},{"issue":"3","key":"4261_CR80","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1159\/000328516","volume":"19","author":"Y Wu","year":"2011","unstructured":"Wu Y, Li X, Zhu JX, Xie W, Le W, Fan Z, Jankovic J, Pan T (2011) Resveratrol-activated AMPK\/SIRT1\/autophagy in cellular models of Parkinson\u2019s disease. Neuro-Signals 19(3):163\u2013174. https:\/\/doi.org\/10.1159\/000328516","journal-title":"Neuro-Signals"},{"issue":"10","key":"4261_CR81","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1002\/mnfr.201600111","volume":"60","author":"Y-J Guo","year":"2016","unstructured":"Guo Y-J, Dong S-Y, Cui X-X, Feng Y, Liu T, Yin M, Kuo S-H, Tan E-K, Zhao W-J, Wu Y-C (2016) Resveratrol alleviates MPTP-induced motor impairments and pathological changes by autophagic degradation of \u03b1-synuclein via SIRT1-deacetylated LC3. Mol Nutr Food Res 60(10):2161\u20132175. https:\/\/doi.org\/10.1002\/mnfr.201600111","journal-title":"Mol Nutr Food Res"},{"key":"4261_CR82","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.brainres.2016.05.026","volume":"1646","author":"S Sarkar","year":"2016","unstructured":"Sarkar S, Jun S, Rellick S, Quintana DD, Cavendish JZ, Simpkins JW (2016) Expression of microRNA-34a in Alzheimer\u2019s disease brain targets genes linked to synaptic plasticity, energy metabolism, and resting state network activity. Brain Res 1646:139\u2013151. https:\/\/doi.org\/10.1016\/j.brainres.2016.05.026","journal-title":"Brain Res"},{"key":"4261_CR83","doi-asserted-by":"publisher","unstructured":"Arora T, Prashar V, Singh R, Barwal TS, Changotra H, Sharma A, Parkash J (2022) Dysregulated miRNAs in progression and pathogenesis of Alzheimer\u2019s disease. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-022-02950-z","DOI":"10.1007\/s12035-022-02950-z"},{"issue":"1","key":"4261_CR84","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ydbio.2018.04.009","volume":"447","author":"NJ Palmisano","year":"2019","unstructured":"Palmisano NJ, Mel\u00e9ndez A (2019) Autophagy in C. elegans development. Dev Biol 447(1):103\u2013125. https:\/\/doi.org\/10.1016\/j.ydbio.2018.04.009","journal-title":"Dev Biol"},{"issue":"4","key":"4261_CR85","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.yexcr.2009.10.018","volume":"316","author":"A Maloverjan","year":"2010","unstructured":"Maloverjan A, Piirsoo M, Michelson P, Kogerman P, Osterlund T (2010) Identification of a novel serine\/threonine kinase ULK3 as a positive regulator of hedgehog pathway. Exp Cell Res 316(4):627\u2013637. https:\/\/doi.org\/10.1016\/j.yexcr.2009.10.018","journal-title":"Exp Cell Res"},{"issue":"1","key":"4261_CR86","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1128\/mcb.01082-08","volume":"29","author":"EY Chan","year":"2009","unstructured":"Chan EY, Longatti A, McKnight NC, Tooze SA (2009) Kinase-inactivated ULK proteins inhibit autophagy via their conserved C-terminal domains using an Atg13-independent mechanism. Mol Cell Biol 29(1):157\u2013171. https:\/\/doi.org\/10.1128\/mcb.01082-08","journal-title":"Mol Cell Biol"},{"issue":"5","key":"4261_CR87","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1021\/acschemneuro.8b00460","volume":"10","author":"Z Yang","year":"2019","unstructured":"Yang Z, Li T, Li S, Wei M, Qi H, Shen B (2019) Altered expression levels of MicroRNA-132 and Nurr1 in peripheral blood of Parkinson\u2019s disease. Potential Disease Biomarkers 10(5):2243\u20132249. https:\/\/doi.org\/10.1021\/acschemneuro.8b00460","journal-title":"Potential Disease Biomarkers"},{"issue":"1","key":"4261_CR88","doi-asserted-by":"publisher","first-page":"10755","DOI":"10.1038\/s41598-020-67549-7","volume":"10","author":"M Oh","year":"2020","unstructured":"Oh M, Kim SY, Gil J-E, Byun J-S, Cha D-W, Ku B, Lee W, Kim W-K, Oh K-J, Lee E-W, Bae K-H, Lee SC, Han B-S (2020) Nurr1 performs its anti-inflammatory function by regulating RasGRP1 expression in neuro-inflammation. Sci Rep 10(1):10755. https:\/\/doi.org\/10.1038\/s41598-020-67549-7","journal-title":"Sci Rep"},{"issue":"7466","key":"4261_CR89","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nature12524","volume":"501","author":"JS Pearson","year":"2013","unstructured":"Pearson JS, Giogha C, Ong SY, Kennedy CL, Kelly M, Robinson KS, Lung TW, Mansell A, Riedmaier P, Oates CV, Zaid A, M\u00fchlen S, Crepin VF, Marches O, Ang CS, Williamson NA, O\u2019Reilly LA, Bankovacki A, Nachbur U, Infusini G, Webb AI, Silke J, Strasser A, Frankel G, Hartland EL (2013) A type III effector antagonizes death receptor signalling during bacterial gut infection. Nature 501(7466):247\u2013251. https:\/\/doi.org\/10.1038\/nature12524","journal-title":"Nature"},{"issue":"5","key":"4261_CR90","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.molcel.2006.04.018","volume":"22","author":"PE Carrington","year":"2006","unstructured":"Carrington PE, Sandu C, Wei Y, Hill JM, Morisawa G, Huang T, Gavathiotis E, Wei Y, Werner MH (2006) The structure of FADD and its mode of interaction with procaspase-8. Mol Cell 22(5):599\u2013610. https:\/\/doi.org\/10.1016\/j.molcel.2006.04.018","journal-title":"Mol Cell"},{"issue":"2","key":"4261_CR91","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1212\/WNL.58.2.308","volume":"58","author":"A Hartmann","year":"2002","unstructured":"Hartmann A, Mouatt\u2013Prigent A, Faucheux BA, Agid Y, Hirsch EC (2002) FADD: a link between TNF family receptors and caspases in Parkinson\u2019s disease. Neurology 58(2):308. https:\/\/doi.org\/10.1212\/WNL.58.2.308","journal-title":"Neurology"},{"issue":"9","key":"4261_CR92","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1007\/s00277-019-03737-4","volume":"98","author":"K Srinoun","year":"2019","unstructured":"Srinoun K, Sathirapongsasuti N, Paiboonsukwong K, Sretrirutchai S, Wongchanchailert M, Fucharoen S (2019) miR-144 regulates oxidative stress tolerance of thalassemic erythroid cell via targeting NRF2. Ann Hematol 98(9):2045\u20132052. https:\/\/doi.org\/10.1007\/s00277-019-03737-4","journal-title":"Ann Hematol"},{"key":"4261_CR93","doi-asserted-by":"publisher","unstructured":"Wang R, Tan J, Chen T, Han H, Tian R, Tan Y, Wu Y, Cui J, Chen F, Li J, Lv L, Guan X, Shang S, Lu J, Zhang Z (2019) ATP13A2 facilitates HDAC6 recruitment to lysosome to promote autophagosome-lysosome fusion. 218(1):267\u2013284. https:\/\/doi.org\/10.1083\/jcb.201804165","DOI":"10.1083\/jcb.201804165"},{"issue":"5","key":"4261_CR94","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s11910-018-0829-3","volume":"18","author":"J-S Park","year":"2018","unstructured":"Park J-S, Davis RL, Sue CM (2018) Mitochondrial dysfunction in Parkinson\u2019s disease: new mechanistic insights and therapeutic perspectives. Curr Neurol Neurosci Rep 18(5):21\u201321. https:\/\/doi.org\/10.1007\/s11910-018-0829-3","journal-title":"Curr Neurol Neurosci Rep"},{"key":"4261_CR95","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3389\/fnmol.2013.00040","volume":"6","author":"SM Heman-Ackah","year":"2013","unstructured":"Heman-Ackah SM, Hallegger M, Rao MS, Wood MJ (2013) RISC in PD: the impact of microRNAs in Parkinson\u2019s disease cellular and molecular pathogenesis. Front Mol Neurosci 6:40. https:\/\/doi.org\/10.3389\/fnmol.2013.00040","journal-title":"Front Mol Neurosci"},{"issue":"8","key":"4261_CR96","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1038\/ng2079","volume":"39","author":"JM Franco-Zorrilla","year":"2007","unstructured":"Franco-Zorrilla JM, Valli A, Todesco M, Mateos I, Puga MI, Rubio-Somoza I, Leyva A, Weigel D, Garc\u00eda JA, Paz-Ares J (2007) Target mimicry provides a new mechanism for regulation of microRNA activity. Nat Genet 39(8):1033\u20131037. https:\/\/doi.org\/10.1038\/ng2079","journal-title":"Nat Genet"},{"issue":"11","key":"4261_CR97","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1080\/15476286.2016.1236172","volume":"13","author":"KW Witwer","year":"2016","unstructured":"Witwer KW, Halushka MK (2016) Toward the promise of microRNAs - enhancing reproducibility and rigor in microRNA research. RNA Biol 13(11):1103\u20131116. https:\/\/doi.org\/10.1080\/15476286.2016.1236172","journal-title":"RNA Biol"},{"issue":"17","key":"4261_CR98","doi-asserted-by":"publisher","first-page":"12726","DOI":"10.1074\/jbc.M109.086827","volume":"285","author":"E Doxakis","year":"2010","unstructured":"Doxakis E (2010) Post-transcriptional regulation of alpha-synuclein expression by mir-7 and mir-153. J Biol Chem 285(17):12726\u201312734. https:\/\/doi.org\/10.1074\/jbc.M109.086827","journal-title":"J Biol Chem"},{"issue":"17","key":"4261_CR99","doi-asserted-by":"publisher","first-page":"4973","DOI":"10.1093\/nar\/gkg707","volume":"31","author":"A Boutla","year":"2003","unstructured":"Boutla A, Delidakis C, Tabler M (2003) Developmental defects by antisense-mediated inactivation of micro-RNAs 2 and 13 in Drosophila and the identification of putative target genes. Nucleic Acids Res 31(17):4973\u20134980. https:\/\/doi.org\/10.1093\/nar\/gkg707","journal-title":"Nucleic Acids Res"},{"key":"4261_CR100","doi-asserted-by":"publisher","unstructured":"Calin G, Croce C (2008) RNA as a therapeutic molecule. In. pp 691\u2013699. https:\/\/doi.org\/10.1016\/B978-141603703-3.10057-3","DOI":"10.1016\/B978-141603703-3.10057-3"},{"issue":"1","key":"4261_CR101","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1758-907X-3-1","volume":"3","author":"J Stenvang","year":"2012","unstructured":"Stenvang J, Petri A, Lindow M, Obad S, Kauppinen SJS (2012) Inhibition of microRNA function by antimiR oligonucleotides. Silence 3(1):1\u201317. https:\/\/doi.org\/10.1186\/1758-907X-3-1","journal-title":"Silence"},{"issue":"11","key":"4261_CR102","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1261\/rna.2414110","volume":"16","author":"MS Ebert","year":"2010","unstructured":"Ebert MS, Sharp PA (2010) MicroRNA sponges: progress and possibilities. RNA (New York NY) 16(11):2043\u20132050. https:\/\/doi.org\/10.1261\/rna.2414110","journal-title":"RNA (New York NY)"},{"key":"4261_CR103","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/978-1-60761-863-8_3","volume":"676","author":"Z Wang","year":"2011","unstructured":"Wang Z (2011) The principles of MiRNA-masking antisense oligonucleotides technology. Methods Mol Biol 676:43\u201349. https:\/\/doi.org\/10.1007\/978-1-60761-863-8_3","journal-title":"Methods Mol Biol"},{"issue":"6","key":"4261_CR104","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1096\/fj.13-248880","volume":"28","author":"MA Lopez-Ramirez","year":"2014","unstructured":"Lopez-Ramirez MA, Wu D, Pryce G, Simpson JE, Reijerkerk A, King-Robson J, Kay O, de Vries HE, Hirst MC, Sharrack B, Baker D, Male DK, Michael GJ, Romero IA (2014) MicroRNA-155 negatively affects blood\u2013brain barrier function during neuroinflammation. FASEB J 28(6):2551\u20132565. https:\/\/doi.org\/10.1096\/fj.13-248880","journal-title":"FASEB J"},{"key":"4261_CR105","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.addr.2014.05.009","volume":"81","author":"Y Chen","year":"2015","unstructured":"Chen Y, Gao DY, Huang L (2015) In vivo delivery of miRNAs for cancer therapy: challenges and strategies. Adv Drug Deliv Rev 81:128\u2013141. https:\/\/doi.org\/10.1016\/j.addr.2014.05.009","journal-title":"Adv Drug Deliv Rev"},{"issue":"5\u20136","key":"4261_CR106","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.drudis.2012.10.002","volume":"18","author":"DM Pereira","year":"2013","unstructured":"Pereira DM, Rodrigues PM, Borralho PM, Rodrigues CM (2013) Delivering the promise of miRNA cancer therapeutics. Drug Discovery Today 18(5\u20136):282\u2013289. https:\/\/doi.org\/10.1016\/j.drudis.2012.10.002","journal-title":"Drug Discovery Today"},{"issue":"1","key":"4261_CR107","doi-asserted-by":"publisher","first-page":"e55214","DOI":"10.1371\/journal.pone.0055214","volume":"8","author":"DW Thomson","year":"2013","unstructured":"Thomson DW, Bracken CP, Szubert JM, Goodall GJ (2013) On measuring miRNAs after transient transfection of mimics or antisense inhibitors. PLoS ONE 8(1):e55214\u2013e55214. https:\/\/doi.org\/10.1371\/journal.pone.0055214","journal-title":"PLoS ONE"},{"issue":"2","key":"4261_CR108","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","volume":"20","author":"MJ Mitchell","year":"2021","unstructured":"Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R (2021) Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discovery 20(2):101\u2013124. https:\/\/doi.org\/10.1038\/s41573-020-0090-8","journal-title":"Nat Rev Drug Discovery"},{"issue":"17","key":"4261_CR109","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.4155\/fmc.14.116","volume":"6","author":"V Baumann","year":"2014","unstructured":"Baumann V, Winkler J (2014) miRNA-based therapies: strategies and delivery platforms for oligonucleotide and non-oligonucleotide agents. Future Med Chem 6(17):1967\u20131984. https:\/\/doi.org\/10.4155\/fmc.14.116","journal-title":"Future Med Chem"},{"key":"4261_CR110","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jconrel.2019.10.007","volume":"313","author":"SWL Lee","year":"2019","unstructured":"Lee SWL, Paoletti C, Campisi M, Osaki T, Adriani G, Kamm RD, Mattu C, Chiono V (2019) MicroRNA delivery through nanoparticles. J Control Release 313:80\u201395. https:\/\/doi.org\/10.1016\/j.jconrel.2019.10.007","journal-title":"J Control Release"},{"issue":"9","key":"4261_CR111","doi-asserted-by":"publisher","first-page":"e252","DOI":"10.1038\/mtna.2015.23","volume":"4","author":"JK Lam","year":"2015","unstructured":"Lam JK, Chow MY, Zhang Y, Leung SW (2015) siRNA versus miRNA as therapeutics for gene silencing. Mol Ther Nucleic Acids 4(9):e252. https:\/\/doi.org\/10.1038\/mtna.2015.23","journal-title":"Mol Ther Nucleic Acids"},{"issue":"3","key":"4261_CR112","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/mt.2009.15","volume":"17","author":"FP Manfredsson","year":"2009","unstructured":"Manfredsson FP, Rising AC, Mandel RJ (2009) AAV9: a potential blood-brain barrier buster. Mol Ther 17(3):403\u2013405. https:\/\/doi.org\/10.1038\/mt.2009.15","journal-title":"Mol Ther"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-024-04261-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-024-04261-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-024-04261-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T11:07:13Z","timestamp":1736334433000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-024-04261-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,1]]},"references-count":112,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["4261"],"URL":"https:\/\/doi.org\/10.1007\/s12035-024-04261-x","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,1]]},"assertion":[{"value":"5 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"I, Dr. Jyoti Parkash, give my consent to publish \u201cMechanistic evaluation of microRNAs and their targeted genes in the pathogenesis and therapeutics of Parkinson\u2019s disease\u201d to be published in your prestige journal <i>Molecular Neurobiology<\/i>.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}